What is ischemic hepatitis (shock liver)?

What is Ischemic Hepatitis (Shock Liver)?

Ischemic hepatitis, also known as "shock liver" or hypoxic hepatitis, is a syndrome of acute diffuse liver injury caused by hepatic hypoperfusion, characterized by a massive but transient rise in serum aminotransferases (typically >1000 IU/L) occurring after cardiac arrest, severe hypovolemia/hypotension, or severe congestive heart failure 1.

Pathophysiology

The condition results from a "two-hit" mechanism where the liver is first rendered vulnerable by underlying cardiac dysfunction (particularly right heart failure causing hepatic congestion), then subsequently exposed to systemic hypoperfusion and ischemia 2. Importantly, documented hypotension is not always present—occurring in only 50% of cases 1, 3. The injury involves:

• Centrilobular hepatocyte necrosis due to reduced oxygen delivery
• Hepatic congestion from right heart failure
• Reduced hepatic blood flow
• Total body hypoxemia
• Impaired oxygen uptake by hepatocytes
• Potential reperfusion injury 4

Clinical Presentation

Key Features:

• Markedly elevated aminotransferases (AST and ALT) that respond rapidly to stabilization of circulatory problems 1
• Elevated LDH 5
• Simultaneous onset of renal dysfunction and muscle necrosis may occur 1
• Evidence of cardiac dysfunction on echocardiogram 1

Underlying Conditions:

The most common predisposing conditions are 4, 3:

1. Cardiac failure (most common)
2. Circulatory failure (septic shock)
3. Respiratory failure

Drug-induced hypoperfusion may occur with long-acting niacin, cocaine, or methamphetamine 1.

Epidemiology and Prognosis

• Incidence in ICU settings: 2.5-10% 4
• In-hospital mortality exceeds 50% 4, 3
• Death typically results from the underlying predisposing condition rather than liver injury itself 4
• Patients requiring vasopressor therapy have significantly increased mortality risk 6

Management

Cardiovascular support is the treatment of choice 1. The approach includes:

Primary Treatment:

• Correct the underlying hemodynamic disturbance (heart failure, shock state, respiratory failure) 1, 3
• Optimize cardiac output and hepatic perfusion
• Address hypoxemia

Monitoring for Complications:

• Hypoglycemia
• Hyperglycemia
• Hyperammonemia
• Hepatopulmonary syndrome 4, 6

Emerging Therapies:

Recent studies suggest potential utility of N-acetylcysteine (NAC), though this remains investigational 7.

Critical Distinctions

Transplantation is seldom indicated for ischemic hepatitis 1, distinguishing it from other causes of acute liver failure. The ability to successfully manage the underlying cardiac or circulatory problem determines patient outcome 1.

Common Pitfalls

• Misnomer alert: The terms "ischemic hepatitis" and "shock liver" are technically misnomers since shock states occur in only 50% of cases, and multiple hemodynamic mechanisms beyond pure ischemia contribute (passive congestion, arterial hypoxemia, dysoxia) 3
• Don't delay diagnosis: Early recognition and prompt treatment of the underlying condition is of central prognostic importance 6
• Don't overlook the multifactorial nature: Most patients have multiple contributing factors rather than a single cause 6